Completed PHASE3 INTERVENTIONAL 2-arm NCT00970931

Hypertension Prevention in Pre-Hypertensive Individuals (PREVER)

Prevention of Hypertension in Patients With Pre-hypertension: PREVER-prevention Study

Sponsor: Financiadora de Estudos e Projetos

Conditions Cardiovascular Disease Hypertension Pre-hypertension

Interventions Chlorthalidone plus amiloride placebo

Updated 5 times since 2017 Last updated: Feb 11, 2015 Started: Jul 31, 2010 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00970931, this PHASE3 trial focuses on Cardiovascular Disease and Hypertension and remains completed. Sponsored by Financiadora de Estudos e Projetos, it has been updated 5 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Financiadora de Estudos e Projetos
Hospital de Clinicas de Porto Alegre

Data source: Hospital de Clinicas de Porto Alegre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Porto Alegre, Brazil